Genetic controller prepares immune system for diverse threats

September 11, 2011 in Genetics

An army of immune cells circulates the human body to protect against its potential foes—viruses, bacteria, cancer cells, and other invaders. Because the immune system cannot know what to expect, it must be prepared to fend off virtually any foreign pathogen it might encounter. Now, Howard Hughes Medical Institute scientists have identified a genetic regulator that controls the reshuffling of gene segments that immune cells use to manufacture billions of distinct antibodies and pathogen-recognizing receptors from a limited number of genes.

Mutating that regulatory region, the scientists have discovered, causes a cell to create an incorrect mishmash of antibody parts. The finding is important not only for understanding how antibodies are made, but for understanding how gene regulation can be coordinated across distant regions of the genome. The research was published on September 11, 2011, in the journal Nature.

HHMI investigator Frederick W. Alt of Children’s Hospital Boston, who has spent his career studying how the immune system generates diverse antibodies, says the discovery of this master regulator is the culmination of decades of work in his lab. “This site impacts every regulatory process that we’ve been studying for 30 years,” he explains.

A typical antibody is a Y-shaped molecule made up of four chains: two identical short chains and two identical long – or heavy – chains. The part of antibodies that Alt focuses on, called the immunoglobulin heavy chain (IgH), is composed of three distinct segments: Variable (V), Diversity (D), and Joining (J). Hundreds of versions of the genes that encode these three segments are scattered throughout the genome, separated by long stretches of DNA. To prepare for antibody production, a developing immune cell stitches together one V segment, one D segment, and one J segment to form a gene that encodes a single heavy chain. Gene reshuffling creates about 100 billion possible combinations of the three segments. While each immune cell will generate many copies of the same antibody, the random selection of gene segments that takes place in each cell generates an assortment of antibodies to equip the to recognize many molecules.

Alt had previously found that IgH formation always begins with the combination of a J and a D gene segment. It’s only later than a V is added. Because of this specific ordering, Alt suspected that genes that control the steps of so-called V(D)J recombination may lie in the area between the D and V segments. When his lab started to look more closely at the region, they saw tell-tale signs of genetic regulatory sequences.

“All these marks on the structure of the DNA said that this region had something active about it,” says Alt.

Now, he’s found one stretch of DNA that controls the timing of V(D)J recombination. Normally, Alt says, a protein binds to the site and forms loops of DNA that bring together the variable gene segments, but also act like a brick wall. The looped DNA before the V gene segments stops the cell from adding them to the chain before the J and D are combined. But when Alt’s lab mutated the site, V genes are stitched on too early. Moreover, the cell starts to favor V segments that that lie in closer proximity. This depletes the normal randomness of antibody formation. “By mutating this one site,” says Alt. “You lose the ability to make a diverse repertoire of antibodies.”

Alt suspects the region contains other regulatory elements, as well. There are many questions left to answer about how antibody diversity is generated.

“There are likely other factors binding this region that play a role in this process as well,” says Alt. “We don’t think we’ve finished figuring out how this works.”

Most of the known regulatory elements of genes are in the DNA directly flanking the gene. But in the case of antibodies, the many V, D, and J gene segments are so spread out that any must be acting across long distances. The newly discovered site only explains in part how this is accomplished. More work, Alt says, will reveal how the cell can control such spatially distant genes at once, ensuring that they are transcribed and combined properly.

“The immunoglobulin gene locus has always served as a pioneering place to look at gene regulation because it’s so complex and uses all these examples of regulation,” he says. “Enhancers were discovered there, as well as recombination mechanisms, and repair pathways. And now the immunoglobulin genes are providing us with a system to define how gene expression can be regulated over long distances.”

Provided by Howard Hughes Medical Institute search and more info website

5 /5 (5 votes)  

Rank 5 /5 (5 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Researchers identify new circadian clock component

Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.

Genetics created May 16, 2013 | popularity 3 / 5 (1) | comments 1 | with audio podcast

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Genetics created May 16, 2013 | popularity 5 / 5 (1) | comments 3 | with audio podcast

Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing

In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0

Experts urge caution over use of new genetic sequencing techniques

The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0

Collecting DNA for human rights: How to help while safeguarding privacy

DNA databases might help identify victims of crime and human trafficking, but how do we safeguard the personal privacy of innocent victims and family members? A new report online May 15 in the Cell Press journal Trends in ...

Genetics created May 15, 2013 | popularity not rated yet | comments 0


Neurons that can multitask greatly enhance the brain's computational power, study finds

Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...

Team finds mechanism linking key inflammatory marker to cancer

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.

New study identifies risk factors for depression among COPD patients

Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall ...

Youth bullying because of perceived sexual orientation widespread and damaging

(Medical Xpress)—Bullying because of perceived sexual orientation is prevalent among school-aged youths, according to a study led by Donald Patrick, professor of health services at the UW School of Public ...

Inflammatory bowel disease raises risk of melanoma

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Pharmaceutical advances offer new options for health outcomes

Research presented at Digestive Disease Week (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.